Bone Marrow Transplantation (BMT) is a useful strategy for the treatment of leukemia, severe combined immune deficiency, enzyme deficiencies, autoimmune disease, and osteoporosis. Furthermore, BMT plays an important role in the induction of immune tolerance in organ transplantation. Bone marrow is a spongy tissue, and is made up of Hematopietic Stem Cells (HSCs), Mesenchymal Stem Cells (MSCs), and various blood cells. HSCs differentiate into common myeloid- and lymphoid-precursor cells and then terminally differentiate into erythrocytes, monocytes, platelets, neutrophils, dendritic cells and other cells. MSCs can differentiate into not only mesoderm derived-cells such as adipocytes, osteoblasts, and osteoclasts, but also endodermand ectoderm-derived cells. Intra-Bone Marrow-BMT (IBM-BMT) has been proven to be the best strategy for allogeneic BMT as it results in the rapid recovery of hemopoietic function and the restoration of T cell functions since it can replace not only HSCs but also MSCs.
Susumu Ikehara, Advances in Leukemia Treatment with Bone Marrow Transplantation
Impact Factor is a population statistic that reflects how many citations of a journalâs papers published over a two-year period receive during the subsequent year. âThe annual Journal Citation Reports impact factor is a ratio between citations and recent citable items published: a journalâs impact factor is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.Medical Journals provide a podium for unresolved research around the globe in the field of medicine. Medical journals contribute for the advancement and development of the scientific discoveries. Medical journals publish papers which provide information on diagnosis, treatment & prevention of various diseases.
Last date updated on July, 2014